Home > News > Nanogen Reports 2003 Fourth Quarter and Year-End
February 18th, 2004
Nanogen Reports 2003 Fourth Quarter and Year-End
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular diagnostic products, today announced its financial results for the fourth quarter and year ended December 31, 2003. Total revenues for the quarter ended December 31, 2003 were $2.1 million compared to $1.7 million in the third quarter of 2003 and $12.1 million in the fourth quarter of 2002. Fourth quarter product revenue increased by 45% over the prior quarter on the basis of eight new instrument sales and one reagent rental.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
Industrial Nanotech, Inc. to Publish PCAOB Audited Financials July 31st, 2014
Nanometrics Reports Second Quarter 2014 Financial Results July 30th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014